Device Craniomaxillofacial

Adherus Autospray Dural Sealant

Payments companies reported to CMS as associated with Adherus Autospray Dural Sealant. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$61Kassociated payments (2023-2025)
717clinicians with associated payments
1company reporting

By year

2023 $18K
2024 $24K
2025 $20K

Payments reported as associated with Adherus Autospray Dural Sealant, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $30K
Otolaryngology $5,888
Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,196
Physician Assistant $2,233
Surgical $1,627
Family $1,095

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Adherus Autospray Dural Sealant

These are the largest totals companies reported as associated with Adherus Autospray Dural Sealant. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Thomas Caranasos Naples, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,970.82
Adam Williams Miami, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,225.00
Jason Sheehan Charlottesville, VA Neurological Surgery $697.50
David Mccracken Atlanta, GA Neurological Surgery $550.00
Justin Singer Grand Rapids, MI Neurological Surgery $450.00
Bryan Figueroa Grand Rapids, MI Neurological Surgery $450.00
Andrew Montoure Seattle, WA Neurological Surgery $429.79
Kunal Vakharia Tampa, FL Neurological Surgery $408.39
Daniel Hammer San Diego, CA Oral and Maxillofacial Surgery $400.00
Daniel Lilly Cleveland, OH $369.73

Prescribed Adherus Autospray Dural Sealant?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.